Angiogenesis extent and expression of matrix metalloproteinase‐2 and ‐9 agree with progression of ovarian endometriomas
article
OA: closed
CC0
⤵ 40 in-corpus citations
AI-generated summary
Ovarian endometriomas show increased angiogenesis and matrix metalloproteinase-2 and -9 mRNA expression, particularly in stage IV disease, correlating with disease progression.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BACKGROUND: Changes in angiogenesis and expression of extracellular matrix-degrading enzymes have been substantiated in tumour changeover and progression. METHODS: Tissues from 44 biopsies of stage III and IV ovarian endometriomas, and 10 biopsies of normal (control) endometrium were investigated immunohistochemically to count microvessels, and by in situ hybridization to assess the expression of mRNA of matrix metalloproteinase-2 (MMP-2) and MMP-9. Implants of the tissues were investigated in the chick embryo chorioallantoic membrane (CAM) assay to determine their angiogenic capacity. RESULTS: The endometriomas displayed significantly higher counts than normal endometria and the highest values were associated with the deepest invasion level (stage IV). Microvessels localized in close association with ectopic endometrial cells in the form of winding and arborized tubes, often dilated in microaneurysmatic segments. These were absent in normal endometrium. Expression of MMP-2 and MMP-9 mRNA, evaluated as percentages of positive biopsies and intensity of expression, was up-regulated in endometriomas and more pronounced in stage IV. MMP-2 and MMP-9 mRNA were also expressed by host stromal cells, including microvascular endothelial cells, fibroblasts and macrophages, whereas the control endometrium showed very little expression of MMP-2 mRNA in a few endothelial cells and no expression of MMP-9 mRNA. Implants from stage IV endometrioma induced a more intense vasoproliferative response than those from stage III, while no vasoproliferative response was induced by the normal endometrium. CONCLUSION: These data suggest that angiogenesis and degradation of extracellular matrix occur together in endometriosis and are more pronounced in stage IV, and that endometriosis cells and some host stromal cell populations co-operate in disease progression.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (47)
- Angiogenesis and Macrophage Activation in Endometriosis via openalex
- Angiogenic activity of peritoneal fluid from women with endometriosis via openalex
- Angiongenesis: a new theory for endometriosis via openalex
- Endometrial vascular and glandular expression of integrin alpha(v)beta3 in women with and without endometriosis via openalex
- Expression of interstitial collagenase (matrix metalloproteinase-1) is related to the activity of human endometriotic lesions via openalex
- Expression of platelet-derived endothelial cell growth factor and its mRNA in uterine endometrium during the menstrual cycle via openalex
- Extracellular matrix remodelling in the endometrium and its possible relevance to the pathogenesis of endometriosis via openalex
- Gonadotropin-Releasing Hormone Agonist (GnRH-a) Therapy Alters Activity of Plasminogen Activators, Matrix Metalloproteinases, and Their Inhibitors in Rat Models for Adhesion Formation and Endometriosis: Potential GnRH-a–Regulated Mechanisms Reducing Adhesion Formation via openalex
- High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomata via openalex
- Increased Mast Cell Density in Peritoneal Endometriosis Compared with Eutopic Endometrium with Endometriosis via openalex
- Matrix Metalloproteinases and Tace Play A Role in The Pathogenesis of Endometriosis via openalex
- Paracrine Regulation of Matrix Metalloproteinase Expression in the Normal Human Endometrium via openalex
- Progesterone and transforming growth factor-β coordinately regulate suppression of endometrial matrix metalloproteinases in a model of experimental endometriosis via openalex
- The expression of interstitial collagenase in human endometrium is controlled by progesterone and by oestradiol and is related to menstruation via openalex
- Vascular endothelial growth factor and endometriotic angiogenesis via openalex
- W2057684012 via openalex
- W2088462647 via openalex
- W2094383633 via openalex
- W2094816691 via openalex
- W2096190665 via openalex
- W2109606512 via openalex
- W2110828317 via openalex
- W2112284922 via openalex
- W2122109193 via openalex
- W2124080049 via openalex
- W2126344014 via openalex
- W2158965678 via openalex
- W2180964475 via openalex
- W2346020725 via openalex
- W2477008945 via openalex
- W4250694871 via openalex
- W53405506 via openalex
- W4251839110 via openalex
- W1433086223 via openalex
- W1546229037 via openalex
- W1573363574 via openalex
- W1964417650 via openalex
- W1966598311 via openalex
- W1980638951 via openalex
- W1982798184 via openalex
- W1987740508 via openalex
- W2011134969 via openalex
- W2029281158 via openalex
- W2030745695 via openalex
- W2047558750 via openalex
- W2054771813 via openalex
- W2055905515 via openalex
Cited by (40)
- Digestive system deep infiltrating endometriosis: What do we know 2023
- Ovarian endometriosis associated infertility: a modern view to the problem 2020
- The levels of matrix metalloproteinase-9 and neutrophil gelatinase-associated lipocalin in different stages of endometriosis 2019
- Increased Expression Levels of Metalloprotease, Tissue Inhibitor of Metalloprotease, Metallothionein, and p63 in Ectopic Endometrium: An Animal Experimental Study 2018
- The bimodal role of matrix metalloproteinases and their inhibitors in etiology and pathogenesis of endometriosis (Review) 2018
- Basic mechanisms of vascularization in endometriosis and their clinical implications 2018
- Drug delivery for the treatment of endometriosis and uterine fibroids 2017
- The DNA methylation status of genes encoding Matrix metalloproteinases and tissue inhibitors of Matrix metalloproteinases in endometriosis 2017
- Overexpression of chloride channel-3 is associated with the increased migration and invasion ability of ectopic endometrial cells from patients with endometriosis 2016
- Association between matrix metalloproteinase-2 and matrix metalloproteinase-9 polymorphisms and endometriosis: A systematic review and meta-analysis 2015
- Effect of warming Yang and removing blood stasis method on matrix metalloproteinases / tissue inhibitor metalloproteinases levels secreted by cultured endometrial cells from patients with endometriosis 2015
- The possible role of zinc in the etiopathogenesis of endometriosis 2014
- Endometriosis 2013
- Endometrioza i proces nowotworowy 2012
- Survivin, MMP-2, MT1-MMP, and TIMP-2: their impact on survival, implantation, and proliferation of endometriotic tissues 2012
- Association Between <scp><i>MMP‐2</i></scp> and <scp><i>TIMP‐2</i></scp> Gene Polymorphisms and Advanced‐Stage Endometriosis in <scp>K</scp>orean Women 2012
- Proteinase-activated receptors in the endometrium and endometriosis 2012
- Differentielle Expressionsmuster von MMP-2, MMP-9 und PCNA in verschiedenen Endometriosestadien und Endometriumkarzinomen 2011
- Matrix metalloproteinases are elevated in the urine of patients with endometriosis 2010
- Endometriomas in adolescents 2010
- Genistein Does Not Affect Vascularization and Blood Perfusion of Endometriotic Lesions and Ovarian Follicles in Dorsal Skinfold Chambers of Syrian Golden Hamsters 2010
- Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model 2009
- Endometriosis 2009
- An investigation of basic science and clinical research methodologies to benefit clinical practice 2009
- Doxycycline causes regression of endometriotic implants: a rat model 2009
- Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises 2008
- Matrix metalloproteinases 2 and 9, E-cadherin, and β-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium 2008
- Serial analysis of gene expression reveals differential expression between endometriosis and normal endometrium. Possible roles for AXL and SHC1 in the pathogenesis of endometriosis 2008
- Role of melatonin in regulating matrix metalloproteinase‐9 via tissue inhibitors of metalloproteinase‐1 during protection against endometriosis 2008
- Pelvic Endometriosis is Rarely Associated with Ovarian Borderline Tumours, Cytologic and Architectural Atypia: A Clinicopathologic Study 2008
- Menstrual effluent in endometriosis shows no difference in volume, VEGF-A, MMP2 and MMP9 or sFLT 2006
- Endometriosis is characterized by an impaired localization of laminin-5 and α3β1 integrin receptor 2006
- The “neurologic hypothesis”: a new concept in the pathogenesis of the endometriosis? 2005
- Possible Involvement of Thrombin/Protease-Activated Receptor 1 System in the Pathogenesis of Endometriosis 2005
- Immunology of endometriosis 2004
- Endometriosis and the neoplastic process 2004
- Inhibiting MMP activity prevents the development of endometriosis in the chicken chorioallantoic membrane model 2004
- Eutopic endometrium and peritoneal, ovarian and bowel endometriotic tissues express a different profile of matrix metalloproteinases-2, -3 and -11, and of tissue inhibitor metalloproteinases-1 and -2 2004
- Ovarian endometriosis 2003
- (no title) 2003
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:13:13.417725+00:00
License: CC0
· commercial use OK